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Disease Investigation through Specialized
Clinically Oriented Ventures in Environmental
Research (DISCOVER) [P50]
The National Institute of Environmental Health
Sciences (NIEHS) invites qualiﬁed investigators from
academic institutions or nonproﬁt research institutions
to submit an application for a Disease Investigation
through Specialized Clinically Oriented Ventures in
Environmental Research (DISCOVER) Center. Each
DISCOVER Center will develop an overarching theme
that is based on a speciﬁc environmentally inﬂuenced
disease or dysfunction and will craft an interdisciplinary
research approach that integrates patient-oriented or
public health research with basic mechanistic studies to
address disease etiology, pathogenesis, susceptibility,
and/or progression. An extraordinary level of synergy,
integration, and potential for advancement of environ-
mental health sciences is expected. By fostering collabo-
rative research these centers will increase the relevance of
basic scientiﬁc discoveries in environmental health sci-
ences to human disease, and move this knowledge into
clinical and public health application to ultimately
improve human health.
NIEHS recognizes that to accomplish this research
agenda, two types of activities need to converge. First,
the research team must focus on a particular human dis-
ease or dysfunction that is likely to be caused or inﬂu-
enced by environmental exposure(s). Second, a team of
physician scientists, research scientists trained in the
basic biomedical disciplines, and public health
researchers will work collaboratively to use toxicant
exposures or environmental perturbations to understand
human disease. Thus, the research conducted by a DIS-
COVER Center will capitalize on multiple aspects of
environmental health sciences research including expo-
sure biology, environmental genetics and genomics,
patient-oriented clinical research, and public health sci-
ences, such as epidemiology, as well as computational
and engineering approaches to define the functional
contributions of environmental and genetic determi-
nants in 1) assessing the risk of developing disease, 2)
identifying the underlying physiological mechanisms in
disease pathogenesis and progression, 3) characterizing
disease phenotype, 4) understanding the environmental
and endogenous factors that affect the distribution of
disease in populations, and 5) applying the knowledge
gained to develop therapeutic, diagnostic, prognostic,
and preventative strategies. 
The mission of the NIEHS is to promote research
that will reduce the harmful effects of environmental
exposures on human health and disease. The link
between environmental agents and disease risk has been
recognized for over a century. It has also been recognized
that there is considerable variability in an individual’s
response and ultimately an individual’s risk to developing
disease as a consequence of exposure to environmental or
lifestyle factors. The completion of the Human Genome
Project has been heralded as the beginning of a new age
of science where the resultant genetic advances will
imminently lead to improvements in human health.
However, our understanding of environmental health
and the development of disease suggests a multifactorial
process involving a complex interplay between genetic
variability, external exposures (i.e., the environment),
temporal vulnerability (i.e., age), and other unique host
factors such as preexisting conditions, nutritional status,
lifestyle choices, and social status. This leads to a daunt-
ing challenge for the environmental health sciences com-
munity to assess the risk of developing disease from
exposures to toxicants/stressors, and to apply this knowl-
edge for improving human health. 
Most common chronic diseases such as cancer,
cardiovascular disease, asthma, diabetes, reproductive
diseases/disorders, autoimmune diseases, and neuro-
behavioral and neurodegenerative disorders are believed
to have multiple genetic and environmental factors con-
tributing to their observed phenotype. For example,
more than 35 genes have been identiﬁed that are likely
to contribute to asthma susceptibility, indicating the
complex etiology and biology of this disease.
Additionally, early life exposures to factors such as
microbial toxins, pet dander, and environmental
tobacco smoke inﬂuence the risk for asthma and related
phenotypes in a genotype-speciﬁc manner, suggesting
that environmental exposures are critical to understand-
ing the underlying pathogenesis of asthma. Similarly,
there is mounting evidence that neurodegenerative dis-
eases such as Parkinson, Alzheimer, and dementia, not
only are strongly inﬂuenced by genetic variables, but
that environmental exposures during vulnerable periods
of early life may contribute to disease etiology. Likewise,
there is increasing evidence that early life exposures to
environmental factors predispose individuals to develop-
ing obesity as adults. Obesity, along with insulin resis-
tance, dyslipidemia, and hypertension are key clinical
features of metabolic syndrome, a common disease asso-
ciated with an increased risk of type 2 diabetes mellitus
and cardiovascular disease. While a direct linkage
between environmental exposures beyond lifestyle fac-
tors such as diet and nutrition has not been made to
date, environmental exposures are likely contributing to
the increasing prevalence of metabolic syndrome. In
aggregate, these observations demonstrate the impor-
tance of environmental exposures in understanding the
etiology, pathogenesis, and prognosis of many complex
human diseases. 
The contribution of the environmental component
in the gene–environment paradigm to the etiology of
human disease has been difﬁcult to ascertain. This is
partly due to the lack of precision in the methods to inte-
grate exposure over time, the inability to characterize the
attributable risk from multiple exposures (i.e., environ-
mental toxicants, nutrition, and lifestyle choices) through
life, and the lack of statistical and computational
approaches to measure complex gene–environment, or
gene–environment–comorbidity interactions. Ultimately
this imprecision in the exposure measurement may
underestimate the involvement of environmental factors
in disease causation. The advent of the omics, transcrip-
tomics, genomics, proteomics, and metabolomics, as well
as nanotechnology and molecular imaging, are creating
new sets of tools that hold promise to better quantify
environmental exposures and assess early indicators of
biological responsiveness. The incorporation of these
approaches offers opportunities to better understand the
underlying biology that confers variability in disease
response as a consequence of exposure. 
Historically, most research conducted by the
NIEHS community has emphasized an assessment of the
toxicologic effects of environmental agents on biological
processes using animal models; in many instances these
studies have not made direct linkages to human disease.
Consequently, the translation of research supported by
the NIEHS into improving human health has not been
as rapid as desired. In the past few years, NIEHS has
developed and supported new programs such as the
Centers for Children's Environmental Health and
Disease Prevention Research (http://www.niehs.
nih.gov/translat/children/children.htm), the Centers for
Population Health and Health Disparities (http://obssr.
od.nih.gov/CPHHD/Index.htm), the Collaborative
Centers for Parkinson's Disease Environmental Research
(http://www.niehs.nih.gov/ccpder/), and the Breast
Cancer and the Environment Research Centers
(http://www.bcerc.org/), which are intended to provide a
human disease focus for the NIEHS.
The DISCOVER Centers program is designed to
further broaden the NIEHS research portfolio in a clini-
cally focused direction, by encouraging the extramural
community to identify and deﬁne the basic and applied
research opportunities likely to have the most profound
impact on the understanding and management of envi-
ronmentally inﬂuenced disease. The NIEHS continues
to be committed to supporting research through investi-
gator-initiated, single-laboratory project grants that focus
on the adverse effects that environmental toxicants/stres-
sors have on cellular and biological processes. However,
the resources required to conduct the multifaceted,
interdisciplinary projects necessary to achieve signiﬁcant
advances in the characterization of human disease, and
accelerate research ﬁndings into clinical and public prac-
tices that impact disease outcome are beyond the scope
of a typical R01 grant. Therefore, the DISCOVER
Center program is being initiated to create an integrated
research approach involving teams of scientists that rep-
resent clinical research, basic biomedical research disci-
plines, and public health sciences. These teams will
focus on complex human diseases or disorders where
there is evidence or a strong rationale for the involve-
ment of environmental factors in its etiology, pheno-
typic expression, or population distribution. As part of
the design for these centers, the research should lead to
improved clinical and public health practices through
advances in prevention, diagnosis and treatment.
Each DISCOVER Center will develop an over-
arching theme that is based on a speciﬁc environmen-
tally inﬂuenced disease or dysfunction and will craft an
interdisciplinary research approach that incorporates
clinical and basic mechanistic studies to address disease
etiology, pathogenesis, susceptibility, progression,
and/or prognosis. An extraordinary level of synergy and
potential for advancement of environmental health sci-
ences is expected through the creation of research pro-
jects that individually are scientiﬁcally meritorious but
together display a high degree of complementarity and
integration. Ultimately, these centers are expected to
accelerate the application of knowledge derived from
basic research into the clinical or public health setting
with the goal of improving human health. The DIS-
COVER program is expected to create opportunities to
develop and apply novel approaches for the diagnosis,
prognosis, prevention, and treatment/intervention of
environmentally inﬂuenced diseases or disorders. 
The general characteristics of a DISCOVER
Center to promote the goals of this initiative include:
1) a central theme that identiﬁes a speciﬁc human dis-
ease or dysfunction to be studied, and well-articulated
hypotheses that promote collaboration and integration
between projects; 2) a series of collaborative research
projects that work at the interface between environmen-
tal exposures, basic biology, genomics/genetics, clinical
sciences, and population-based studies and incorporate
biological model systems such as patient cohorts, geneti-
cally manipulated mouse strains, or human or animal
cell lines; 3) an experimental approach that, in part,
incorporates the concepts of environmental health sci-
ences to understand human disease by employing envi-
ronmental toxicants or stressors to elucidate how genes
affect normal cellular or pathophysiological processes,
assess how genetic variation contributes to individual
susceptibility and the phenotypic diversity of human
disease, or explain interindividual variability in etiology,
pathogenesis, or prognosis; 4) a research plan to facili-
tate the extension of knowledge gained to clinical and/or
public health practice.
A DISCOVER Center must reﬂect an integrated
research enterprise that will advance our understanding
of how environmental stimuli interact with biological
processes to either preserve health or cause disease.
Applicants may focus their center on any human disease
or dysfunction provided there is adequate justiﬁcation
for the role of primary environmental stressors in inﬂu-
encing disease etiology, progression, prognosis, or popu-
lation distribution. The NIEHS deﬁnes environment
quite broadly, and for this initiative considers chemical,Fellowships, Grants, & Awards
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physical, or biological toxicants as primary stressors. In
addition to a focus on primary stressors, applicants
should investigate the effects of secondary modifiers
such as co-morbid disease/conditions, aging, diet, infec-
tious disease, and/or idiosyncratic drug reactions that
have the possibility to influence the susceptibility to
physical or environmental toxicant exposures and
thereby alter disease processes. For this initiative propos-
als focusing solely on secondary modiﬁers, including but
not limited to smoking, alcohol, infectious agents, or
diet, in the absence of primary exposures, will not be
considered responsive. 
The scientiﬁc theme developed for a DISCOVER
Center should reflect an interdisciplinary research
approach that incorporates multiple levels of scientiﬁc
endeavors. Examples of general themes and approaches
that may be considered appropriate for inclusion within
a DISCOVER Center include but are not limited to the
following suggestions.
Characterize disease occurrence in terms of etiologic
heterogeneity, disease pathogenesis, or by identifying
biological targets for understanding gene–environment
interactions and novel approaches to therapeutic inter-
vention. 1) Use environmental exposures to identify the
cellular and molecular patterns of disease that character-
ize unique biological phenotypes and provide additional
understanding of disease processes. 2) Use environmen-
tal exposure to understand basic mechanisms of disease
pathogenesis. 3) Screen for molecular abnormalities that
relate to particular steps or manifestations of the disease.
4) Use environmental agents as probes to dissect critical
pathway components that lead to, modulate, or aug-
ment the progression or risk of disease. These environ-
mental probes can help develop novel therapeutic/
diagnostic tools. 5) Employ comparative biology and
functional genomic, proteomic, or metabolomic studies
across multiple species in parallel with human studies in
the presence of environmental agents to facilitate the
discovery of basic underlying mechanisms of disease.
Clarify the contribution of environmental and
genetic variables in the risk of developing disease and the
risk of disease progression. 1) Assess the clinical implica-
tions of cellular and molecular patterns for disease sus-
ceptibility, development, or progression and therapeutic
intervention. 2) Investigate the interactions between co-
morbid conditions on individual sensitivity to environ-
mental factors in the disease process. 3) Conduct studies
in well characterized exposed populations to identify
factors that lead to variation in an individual’s suscepti-
bility to disease. These markers of disease susceptibility
could then be further validated within a clinical research
environment to assess the functional relevance of
gene–environment interactions as it contributes to the
development and progression of human disease.
Stratify disease risk and target intervention to pro-
mote improved health at the individual or population
level. 1) Conduct studies in humans that may have
direct diagnostic or therapeutic application, e.g.,
genetic polymorphisms that relate to disease susceptibil-
ity, clinical outcome, or assessing the clinical effective-
ness of a therapeutic intervention. 2) Identify molecular
and cellular targets for novel therapies to mitigate the
effects of environmental exposures. 3) Apply omics,
nanotechnology, and imaging approaches across species
in parallel with human studies to develop biomarkers of
exposure, disease disposition, onset, severity, or progres-
sion. 4) Use environmental agents as tools to under-
stand perturbations in normal cell physiology to
directly link exposure to disease. This could lead to the
identiﬁcation and validation of biomarkers and their
application as prognostic indicators of human diseases
as well as therapeutic efﬁcacy.
A DISCOVER Center must also have a strong
focus on translational research which has been deﬁned
by NIH as studies at the interface of the bench and bed-
side and/or community. Information ﬂow at these inter-
faces is bidirectional, requiring close interaction between
clinical and bench scientists to study human diseases.
The structure of the center should facilitate the accelera-
tion of basic research ﬁndings into practical applications
that benefits clinical and public health practice to
improve human health. Examples include: 1) the devel-
opment of sensitive preclinical markers of exposure and
biological responses; 2) the development of novel thera-
peutic agents and/or diagnostic tools; 3) the develop-
ment of biomarkers for disease phenotype, onset,
severity, or progression; 4) the application of biomarkers
as prognostic indicators of human diseases as well as
therapeutic efﬁcacy. 
The DISCOVER Center supports a full range of
basic, developmental, clinical, public health, and/or
applied research components; and is intended to result
in novel scientific concepts about the etiology and
pathogenesis, and distribution of human diseases. The
ultimate goal of the DISCOVER Centers is to use sci-
entific methods that are unique to environmental
health sciences to further understand human health and
disease.
The DISCOVER Center must have an identiﬁable
organizational unit within a university, medical school,
nonproﬁt research institute, or a consortium of cooper-
ating institutions with a university afﬁliation. The appli-
cant institution must include a minimum of 50% of the
research effort. Partnerships may consist of investigators
at a single institution or at multiple sites and may
include collaborative arrangements as appropriate with
organizations, domestic or foreign, public or private
(such as universities, colleges, hospitals, laboratories, for-
proﬁt and nonproﬁt, units of state and local govern-
ments, and eligible agencies of the federal government),
as necessary to conduct portions of the research. Teams
that are geographically distributed must be well justiﬁed,
and steps to minimize the effects of geography should be
clearly stated. 
The DISCOVER P50 grant mechanism fosters
collaborative and integrated basic, clinical, and public
health research and provides funds to support personnel,
stipends and tuition for trainees, equipment, supplies,
and services for research projects, facility cores, and an
administrative core. 
The director for the DISCOVER Center is the
designated leader and provides the leadership for the
administrative, scientiﬁc, and programmatic direction.
It is expected that the director will commit a minimum
of 15% effort to the administration of the center.
Likewise, the center must reﬂect an emphasis on clinical
research and integration by the identiﬁcation of a lead
physician-scientist whose role is to ensure communica-
tion and translation across the research projects by
devoting a minimum of 15% effort to center adminis-
tration. The physician-scientist can serve as either direc-
tor or associate director of the center.
The research projects provide the intellectual and
scientific direction for the program. These projects
should be well integrated and relate to the theme of the
center. A minimum of four research projects are
required and must include at least two patient-oriented
clinical/public health research projects and two mecha-
nistically driven basic research project. Additional pro-
jects are encouraged. Project leaders are expected to
devote at least 20% effort to these projects.
A required Administrative Core oversees the orga-
nizational, budgeting, and reporting aspects of the DIS-
COVER Center and provides the environment and
infrastructure to promote cross-discipline interactions
among all projects and cores. To aid the center director
in achieving the goals of the program, the establishment
of an external advisory committee is required. The com-
position of the external advisory committee should
reflect the scientific expertise of the center and must
include physician-scientists. The Administrative Core
will also include a plan to support product development
to facilitate the translation of knowledge, resources, and
tools resulting from the research effort to improve
human health.
Facility Cores are designed principally as a service
or resource component to the research projects within
the center. Core facilities may include clinical research
support, biostatistics and/or bioinformatics support, and
basic molecular/cellular capabilities. These cores serve to
enhance or make more cost-effective the services, tech-
niques, or instrumentation used by the center and also
promotes interdisciplinary activities. The DISCOVER
Center should include facility cores that serve at least
two research projects if resources are not available
through other Institutional infrastructure such as P30
Core Centers or other resources such as GCRCs or
Clinical and Translational Science Award Centers
(CTSAs). The number of facility/service cores may not
exceed the total number of research projects and are not
a requirement of the Discover Centers. Applicants must
include a discussion of the cost savings and other efﬁ-
ciencies provided by the inclusion of such core facilities.
This funding opportunity will use the P50 award
mechanism. As an applicant, you will be solely respon-
sible for planning, directing, and executing the
proposed project. 
This funding opportunity uses the just-in-time
budget concepts. It also uses the nonmodular budget
format described in the PHS 398 application instruc-
tions (see http://grants.nih.gov/grants/funding/phs398/
phs398.html). A detailed categorical budget for the
Initial Budget Period and the Entire Proposed Period of
Support is to be submitted with the application. 
The PHS 398 application instructions are available
at http://grants.nih.gov/grants/funding/phs398/
phs398.html in an interactive format. Applicants must
use the currently approved version of the PHS 398. For
further assistance contact GrantsInfo, 301-435-0714
(telecommunications for the hearing impaired: TTY
301-451-0088) or by e-mail: GrantsInfo@nih.gov. 
Applications must be prepared using the most cur-
rent PHS 398 research grant application instructions
and forms. Applications must have a D&B Data
Universal Numbering System (DUNS) number as the
universal identiﬁer when applying for Federal grants or
cooperative agreements. The D&B number can be
obtained by calling 866-705-5711 or through the web
site at http://www.dnb.com/us/. The D&B number
should be entered on line 11 of the face page of the
PHS 398 form. 
The letter of intent receipt date for this RFA is
October 17, 2006, with the application receipt date
November 17, 2006. The complete version of the RFA
is available at http://grants.nih.gov/grants/guide/rfa-
ﬁles/RFA-ES-06-001.html. 
Contact: David M. Balshaw, Center for Risk and
Integrated Sciences, Division of Extramural Research
and Training, National Institute of Environmental
Health Sciences, PO Box 12233, EC-27, 79 T.W.
Alexander Drive, Research Triangle Park, NC 27709
USA, 919-541-2448, fax: 919-541-4937, e-mail:
Balshaw@niehs.nih.gov; Kimberly Gray, Susceptibility
and Population Health Branch, Division on Extramural
Research and Training, National Institute of
Environmental Health Sciences, PO Box 12233, EC-21,
79 T.W. Alexander Drive, Research Triangle Park, NC
27709 USA, 919-541-0293, fax: 919-316-4606, e-mail:
gray6@niehs.nih.gov; Jerry Heindel, Cellular, Organ and
Systems Pathobiology Branch, Division on Extramural
Research and Training, National Institute of
Environmental Health Sciences, PO Box 12233, EC-23,
79 T.W. Alexander Drive, Research Triangle Park, NC
27709 USA, 919-541-0781, fax: 919-541-5064, e-mail:
heindelj@niehs.nih.gov. Reference RFA-ES-06-001